+188.2%
ASML vs BBIO
+159.6%
+28.6%
-45.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.9% | -0.1% | +3.0% | +2.9% |
| 7D | +6.0% | -2.4% | +8.4% | +6.4% |
| 30D | +1.4% | -11.5% | +12.9% | +3.4% |
| 3M | +1.0% | +11.0% | -9.9% | -1.1% |
| 6M | +37.0% | +14.4% | +22.6% | +33.4% |
| YTD | +65.8% | -2.3% | +68.0% | +64.6% |
| 1Y | +123.1% | +37.7% | +85.4% | +109.5% |
| 3Y | +188.2% | +163.1% | +25.0% | +138.3% |
| All | +188.2% | +159.6% | +28.6% | +138.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling